NEULAND LABORATORIES
Back to Income Statement
|
NEULAND LABORATORIES Last 5 Year Profit After Tax History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹364 Cr | ₹260 Cr | ₹300 Cr | ₹164 Cr | ₹64 Cr |
What is the latest Profit After Tax of NEULAND LABORATORIES ?
| Year | Profit After Tax |
|---|---|
| Mar2026 | ₹364 Cr |
| Mar2025 | ₹260 Cr |
| Mar2024 | ₹300 Cr |
| Mar2023 | ₹164 Cr |
| Mar2022 | ₹64 Cr |
How is Profit After Tax of NEULAND LABORATORIES Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹364 Cr | 39.94 | |
| Mar2025 | ₹260 Cr | -13.32 | |
| Mar2024 | ₹300 Cr | 83.51 | |
| Mar2023 | ₹164 Cr | 156.21 | |
| Mar2022 | ₹64 Cr | - | |
Compare Profit After Tax of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹24,288.5 Cr | 0.4% | 5.8% | 30.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹473,509.0 Cr | 0.6% | 6% | 14.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,881.0 Cr | 1.2% | 10.5% | 7.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹190,832.0 Cr | -0.4% | 11% | 40.8% | Stock Analytics | |
| CIPLA | ₹113,894.0 Cr | -1.6% | -2.1% | -4.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,062.8 Cr | -4.6% | -14.8% | -8.4% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 0.4% |
5.8% |
30.4% |
| SENSEX | -1.1% |
-0.2% |
-6.6% |
You may also like the below Video Courses